glp-1 receptor agonist type 1 diabetes trial liraglutide Agonists as Treatments for 2 GLP-1 Receptor Agonists for Weight

Skrobucha A, Pindlowski P, Krajewska N, Grabowski M, Jonik S

Obes Surg 33(4):10171025 Lautenbach A et al (2022) The potential of semaglutide once-weekly in patients without type 2 diabetes with weight regain or insufficient weight loss after bariatric surgerya retrospective analysis

Comparative trials show that long-acting medications (exenatide once weekly, liraglutide, dulaglutide, and semaglutide) provide better glycemic control than short-acting medications (exenatide twice daily and lixisenatide) [90]

Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy

The next chapter will step into what you may not have been told, helping you understand what this treatment offersand where it stops